ID   SH3R2_HUMAN             Reviewed;         729 AA.
AC   Q8TEC5; A8K961; Q08AM9; Q6GMR9; Q8N5S8; Q96LP8;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   10-MAY-2017, entry version 122.
DE   RecName: Full=Putative E3 ubiquitin-protein ligase SH3RF2;
DE            EC=2.3.2.27;
DE   AltName: Full=Heart protein phosphatase 1-binding protein;
DE            Short=HEPP1;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 39;
DE   AltName: Full=RING finger protein 158;
DE   AltName: Full=RING-type E3 ubiquitin transferase SH3RF2 {ECO:0000305};
DE   AltName: Full=SH3 domain-containing RING finger protein 2;
GN   Name=SH3RF2; Synonyms=PPP1R39, RNF158;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, INTERACTION WITH
RP   PPP1CA, TISSUE SPECIFICITY, AND MUTAGENESIS OF VAL-643 AND PHE-645.
RX   PubMed=19945436; DOI=10.1016/j.bbrc.2009.11.123;
RA   Chen C.Y., Lai N.S., Yang J.J., Huang H.L., Hung W.C., Li C.,
RA   Lin T.H., Huang H.B.;
RT   "FLJ23654 encodes a heart protein phosphatase 1-binding protein
RT   (Hepp1).";
RL   Biochem. Biophys. Res. Commun. 391:698-702(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS VARIANTS VARIANTS CYS-267; ARG-592; ILE-687 AND ALA-710.
RC   TISSUE=Colon, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS VARIANTS CYS-267; ARG-592 AND ALA-710.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL
RT   (CD178) by phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH PPP1CA.
RX   PubMed=19389623; DOI=10.1016/j.chembiol.2009.02.012;
RA   Hendrickx A., Beullens M., Ceulemans H., Den Abt T., Van Eynde A.,
RA   Nicolaescu E., Lesage B., Bollen M.;
RT   "Docking motif-guided mapping of the interactome of protein
RT   phosphatase-1.";
RL   Chem. Biol. 16:365-371(2009).
CC   -!- FUNCTION: Inhibits PPP1CA phosphatase activity. May be a E3
CC       ubiquitin-protein ligase (Potential). May play a role in cardiac
CC       function. {ECO:0000269|PubMed:19389623,
CC       ECO:0000269|PubMed:19945436, ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with FASLG and PPP1CA.
CC       {ECO:0000269|PubMed:19389623, ECO:0000269|PubMed:19807924,
CC       ECO:0000269|PubMed:19945436}.
CC   -!- INTERACTION:
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-2130111, EBI-744695;
CC       P62136:PPP1CA; NbExp=3; IntAct=EBI-2130111, EBI-357253;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TEC5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TEC5-2; Sequence=VSP_022058, VSP_022059;
CC       Name=3;
CC         IsoId=Q8TEC5-3; Sequence=VSP_040662;
CC   -!- TISSUE SPECIFICITY: Heart (at protein level). Heart and testis. In
CC       the heart, present in the apex, left atrium, right atrium, left
CC       ventricle and right ventricle, but not in the aorta.
CC       {ECO:0000269|PubMed:19945436}.
CC   -!- DOMAIN: The RING-type zinc finger domain mediates binding to an E2
CC       ubiquitin-conjugating enzyme. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SH3RF family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH31650.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB85025.1; Type=Erroneous termination; Positions=458; Note=Translated as Trp.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK058046; BAB71639.1; -; mRNA.
DR   EMBL; AK074234; BAB85025.1; ALT_TERM; mRNA.
DR   EMBL; AK292576; BAF85265.1; -; mRNA.
DR   EMBL; AC005216; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005351; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011359; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091887; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC031650; AAH31650.2; ALT_INIT; mRNA.
DR   EMBL; BC073914; AAH73914.1; -; mRNA.
DR   EMBL; BC125106; AAI25107.1; -; mRNA.
DR   CCDS; CCDS4280.1; -. [Q8TEC5-1]
DR   RefSeq; NP_689763.3; NM_152550.3.
DR   RefSeq; XP_006714820.1; XM_006714757.1. [Q8TEC5-1]
DR   RefSeq; XP_011535871.1; XM_011537569.2. [Q8TEC5-1]
DR   RefSeq; XP_016864625.1; XM_017009136.1. [Q8TEC5-1]
DR   UniGene; Hs.443728; -.
DR   ProteinModelPortal; Q8TEC5; -.
DR   SMR; Q8TEC5; -.
DR   BioGrid; 127517; 33.
DR   IntAct; Q8TEC5; 14.
DR   STRING; 9606.ENSP00000352028; -.
DR   iPTMnet; Q8TEC5; -.
DR   PhosphoSitePlus; Q8TEC5; -.
DR   BioMuta; SH3RF2; -.
DR   DMDM; 296452957; -.
DR   MaxQB; Q8TEC5; -.
DR   PaxDb; Q8TEC5; -.
DR   PeptideAtlas; Q8TEC5; -.
DR   PRIDE; Q8TEC5; -.
DR   TopDownProteomics; Q8TEC5-1; -. [Q8TEC5-1]
DR   Ensembl; ENST00000359120; ENSP00000352028; ENSG00000156463. [Q8TEC5-1]
DR   Ensembl; ENST00000511217; ENSP00000424497; ENSG00000156463. [Q8TEC5-1]
DR   GeneID; 153769; -.
DR   KEGG; hsa:153769; -.
DR   UCSC; uc003lnt.4; human. [Q8TEC5-1]
DR   CTD; 153769; -.
DR   DisGeNET; 153769; -.
DR   GeneCards; SH3RF2; -.
DR   HGNC; HGNC:26299; SH3RF2.
DR   HPA; HPA035903; -.
DR   HPA; HPA058119; -.
DR   MIM; 613377; gene.
DR   neXtProt; NX_Q8TEC5; -.
DR   OpenTargets; ENSG00000156463; -.
DR   PharmGKB; PA134944983; -.
DR   eggNOG; ENOG410ITG6; Eukaryota.
DR   eggNOG; ENOG410XS5R; LUCA.
DR   GeneTree; ENSGT00760000119190; -.
DR   HOGENOM; HOG000060125; -.
DR   HOVERGEN; HBG082418; -.
DR   InParanoid; Q8TEC5; -.
DR   KO; K12171; -.
DR   OMA; NMFVALH; -.
DR   OrthoDB; EOG091G09B6; -.
DR   PhylomeDB; Q8TEC5; -.
DR   TreeFam; TF105571; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; SH3RF2; human.
DR   GenomeRNAi; 153769; -.
DR   PRO; PR:Q8TEC5; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000156463; -.
DR   CleanEx; HS_SH3RF2; -.
DR   Genevisible; Q8TEC5; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0019902; F:phosphatase binding; IDA:UniProtKB.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IDA:UniProtKB.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR011511; SH3_2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR028511; SH3RF2.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR10663:SF233; PTHR10663:SF233; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00326; SH3; 3.
DR   SUPFAM; SSF50044; SSF50044; 3.
DR   PROSITE; PS50002; SH3; 3.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Metal-binding;
KW   Phosphoprotein; Polymorphism; Protein phosphatase inhibitor;
KW   Reference proteome; Repeat; SH3 domain; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    729       Putative E3 ubiquitin-protein ligase
FT                                SH3RF2.
FT                                /FTId=PRO_0000269512.
FT   DOMAIN      125    184       SH3 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      187    252       SH3 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      380    441       SH3 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   ZN_FING      12     53       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION      641    646       Interaction with PPP1CA.
FT   MOD_RES     649    649       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q498M5}.
FT   VAR_SEQ       1    543       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:19945436}.
FT                                /FTId=VSP_040662.
FT   VAR_SEQ       1    508       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022058.
FT   VAR_SEQ     509    519       LRKGRSSMRKN -> MRKSKWWQRD (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022059.
FT   VARIANT      16     16       F -> S (in dbSNP:rs34739859).
FT                                /FTId=VAR_052118.
FT   VARIANT     174    174       F -> V (in dbSNP:rs34942619).
FT                                /FTId=VAR_052119.
FT   VARIANT     267    267       R -> C (in dbSNP:rs758037).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029788.
FT   VARIANT     477    477       R -> Q (in dbSNP:rs35165046).
FT                                /FTId=VAR_052120.
FT   VARIANT     592    592       W -> R (in dbSNP:rs2962525).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029789.
FT   VARIANT     687    687       V -> I (in dbSNP:rs11435).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_029790.
FT   VARIANT     710    710       G -> A (in dbSNP:rs1056149).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029791.
FT   MUTAGEN     643    643       V->G: Significant loss of interaction
FT                                with PPP1CA. Significant loss of
FT                                interaction with PPP1CA; when associated
FT                                with G-645.
FT                                {ECO:0000269|PubMed:19945436}.
FT   MUTAGEN     645    645       F->G: Significant loss of interaction
FT                                with PPP1CA. Significant loss of
FT                                interaction with PPP1CA; when associated
FT                                with G-643.
FT                                {ECO:0000269|PubMed:19945436}.
FT   CONFLICT    148    148       K -> R (in Ref. 2; BAB85025).
FT                                {ECO:0000305}.
FT   CONFLICT    168    168       N -> S (in Ref. 2; BAB85025).
FT                                {ECO:0000305}.
SQ   SEQUENCE   729 AA;  79320 MW;  F85CCC0188DA8477 CRC64;
     MDDLTLLDLL ECPVCFEKLD VTAKVLPCQH TFCKPCLQRV FKAHKELRCP ECRTPVFSNI
     EALPANLLLV RLLDGVRSGQ SSGRGGSFRR PGTMTLQDGR KSRTNPRRLQ ASPFRLVPNV
     RIHMDGVPRA KALCNYRGQN PGDLRFNKGD IILLRRQLDE NWYQGEINGI SGNFPASSVE
     VIKQLPQPPP LCRALYNFDL RGKDKSENQD CLTFLKDDII TVISRVDENW AEGKLGDKVG
     IFPILFVEPN LTARHLLEKN KGRQSSRTKN LSLVSSSSRG NTSTLRRGPG SRRKVPGQFS
     ITTALNTLNR MVHSPSGRHM VEISTPVLIS SSNPSVITQP MEKADVPSSC VGQVSTYHPA
     PVSPGHSTAV VSLPGSQQHL SANMFVALHS YSAHGPDELD LQKGEGVRVL GKCQDGWLRG
     VSLVTGRVGI FPNNYVIPIF RKTSSFPDSR SPGLYTTWTL STSSVSSQGS ISEGDPRQSR
     PFKSVFVPTA IVNPVRSTAG PGTLGQGSLR KGRSSMRKNG SLQRPLQSGI PTLVVGSLRR
     SPTMVLRPQQ FQFYQPQGIP SSPSAVVVEM GSKPALTGEP ALTCISRGSE AWIHSAASSL
     IMEDKEIPIK SEPLPKPPAS APPSILVKPE NSRNGIEKQV KTVRFQNYSP PPTKHYTSHP
     TSGKPEQPAT LKASQPEAAS LGPEMTVLFA HRSGCHSGQQ TDLRRKSALG KATTLVSTAS
     GTQTVFPSK
//
